Pre- and in-hospital intersection of stroke care

Annals of the New York Academy of Sciences

Volumn 1268, Issue 1, 2012, Pages 145-151

  Meretoja, Atte ^a,b,c,d   Kaste, Markku ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

^d FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

Cerebral infarct; Door to needle time; Organization of care; Stroke; Thrombolysis; Thrombolytic therapy

Indexed keywords

ALTEPLASE; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BRAIN ISCHEMIA; COMPUTER ASSISTED TOMOGRAPHY; EMERGENCY CARE; EMERGENCY HEALTH SERVICE; HOSPITAL CARE; HOSPITALIZATION; HUMAN; INFORMED CONSENT; INTERNATIONAL NORMALIZED RATIO; LENGTH OF STAY; PATIENT TRANSPORT; STROKE; STROKE PATIENT; TIME; TREATMENT OUTCOME;

EID: 84866541749     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2012.06664.x     Document Type: Article

References (39)

1. Hatano, S. 1972. WHO Stroke control programme. WHO Chronicle 26: 456-458.
2. Albers, G.W. et al 2002. Transient ischemic attack-proposal for a new definition. N. Engl. J. Med. 347: 1713-1716.
3. Roger, V. L. et al 2012. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 125: e2-e220.
4. Seshadri, S. et al 2006. The lifetime risk of stroke: estimates from the Framingham Study. Stroke 37: 345-350.
5. WHO. 2008. The global burden of disease. 2004 update. Available at: http://www.who.int/healthinfo/bod/en/index.html [accessed 29 June 2012].
6. Goldstein, L.B. et al 2011. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42: 517-584.
7. Furie, K.L. et al 2011. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42: 227-276.
8. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. 1995. Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med. 333: 1581-1587.
9. Hacke, W. et al 2004. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 363: 768-774.
10. Hacke, W. et al 2008. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N. Engl. J. Med. 359: 1317-1329.
11. Lees, K.R. et al 2010. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 375: 1695-1703.
12. Stroke Unit Trialists' Collaboration. 1997. Collaborative systematic review of the randomised trials of organised inpatient (stroke unit) care after stroke. BMJ 314: 1151-1159.
13. Stroke Unit Trialists' Collaboration. 2007. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst. Rev. CD000197.
14. Meretoja, A. et al 2010. Effectiveness of primary and comprehensive stroke centers. PERFECT stroke: a Nationwide Observational Study from Finland. Stroke 41: 1102-1107.
15. Xian, Y. et al 2011. Association between stroke center hospitalization for acute ischemic stroke and mortality. JAMA 305: 373-380.
16. Lichtman, J.H. et al 2011. Outcomes after ischemic stroke for hospitals with and without Joint Commission-certified primary stroke centers. Neurology 76: 1976-1982.
17. Fonarow, G.C. et al 2010. Characteristics, performance measures, and in-hospital outcomes of the first one million stroke and transient ischemic attack admissions in get with the guidelines-stroke. Circ. Cardiovasc. Qual. Outcomes 3: 291-302.
18. Saver, J.L. 2006. Time is brain-quantified. Stroke 37: 263-266.
19. Marler, J.R. et al 2000. Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology 55: 1649-1655.
20. Tilley, B.C. et al 1997. Total quality improvement method for reduction of delays between emergency department admission and treatment of acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Arch. Neurol. 54: 1466-1474.
21. Chiu, D. et al 1998. Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice. Stroke 29: 18-22.
22. Grond, M. et al 1998. Early intravenous thrombolysis for acute ischemic stroke in a community-based approach. Stroke 29: 1544-1549.
23. Albers, G.W. et al 2000. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA 283: 1145-1150.
24. Koennecke, H.C. et al 2001. Intravenous tPA for ischemic stroke team performance over time, safety, and efficacy in a single-center, 2-year experience. Stroke 32: 1074-1078.
25. Wahlgren, N. et al 2007. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 369: 275-282.
26. Sattin, J.A. et al 2006. An expedited code stroke protocol is feasible and safe. Stroke 37: 2935-2939.
27. Fonarow, G.C. et al 2011. Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation 123: 750-758.
28. Kim, S.K. et al 2009. Pre-hospital notification reduced the door-to-needle time for iv t-PA in acute ischaemic stroke. Eur. J. Neurol. 16: 1331-1335.
29. Kohrmann, M. et al 2011. Avoiding in hospital delays and eliminating the three-hour effect in thrombolysis for stroke. Int. J. Stroke 6: 493-497.
30. Meretoja, A. et al 2012. Reducing in-hospital delay to 20 minutes in stroke thrombolysis. Neurology. In press.
31. NINDS Task Force. 2003. Improving the chain of recovery for acute stroke in your community. NIH Publication No. 03-5348. Available at: http://www.ninds.nih.gov/news-and-events/proceedings/acute-stroke-workshop.pdf [accessed on 29 June 2012].
32. The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee. 2008. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc. Dis. (Basel, Switzerland) 25: 457-507.
33. Evenson, K.R. et al 2009. A comprehensive review of prehospital and in-hospital delay times in acute stroke care. Int. J. Stroke 4: 187-199.
34. Wein, T.H. et al 2000. Activation of emergency medical services for acute stroke in a nonurban population: the T.L.L. Temple Foundation Stroke Project. Stroke 31: 1925-1928.
35. Schroeder, E.B. et al 2000. Determinants of use of emergency medical services in a population with stroke symptoms: the Second Delay in Accessing Stroke Healthcare (DASH II) Study. Stroke 31: 2591-2596.
36. Nor, A.M. et al 2004. Agreement between ambulance paramedic- and physician-recorded neurological signs with Face Arm Speech Test (FAST) in acute stroke patients. Stroke 35: 1355-1359.
37. Goldstein, L.B. & D.L. Simel 2005. Is this patient having a stroke? JAMA 293: 2391-2402.
38. Adams, H.P., Jr. et al 2007. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 38: 1655-1711.
39. Fonarow, G.C. et al 2011. Improving door-to-needle times in acute ischemic stroke: The design and rationale for the American Heart Association/American Stroke Association's Target: stroke initiative. Stroke 42: 2983-2989.